Aquestive Therapeutics (AQST) Other Accumulated Expenses (2017 - 2020)

Aquestive Therapeutics' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $201000.0 for Q4 2020.

• In Q4 2020, Other Accumulated Expenses fell 17.28% year-over-year to $201000.0; the TTM figure through Dec 2020 stood at $201000.0 (down 17.28% YoY), while the FY2020 annual figure was $201000.0, down 17.28% from the prior year.
• Other Accumulated Expenses was $201000.0 for Q4 2020 at Aquestive Therapeutics, down from $284000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $284000.0 in Q3 2020 to a low of $97000.0 in Q1 2020.
• Historically, Other Accumulated Expenses has averaged $213916.7 across 4 years, with a median of $215000.0 in 2018.
• Biggest YoY gain for Other Accumulated Expenses was 54.35% in 2020; the steepest drop was 49.48% in 2020.
• A 4-year view of Other Accumulated Expenses shows it stood at $225000.0 in 2017, then dropped by 8.0% to $207000.0 in 2018, then advanced by 17.39% to $243000.0 in 2019, then fell by 17.28% to $201000.0 in 2020.
• The last three Other Accumulated Expenses figures came in at $201000.0 (Q4 2020), $284000.0 (Q3 2020), and $223000.0 (Q2 2020), per Business Quant data.